Gepotidacin
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| Other names | GSK2140944 |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ECHA InfoCard | 100.249.088 |
| Chemical and physical data | |
| Formula | C24H28N6O3 |
| Molar mass | 448.527 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Gepotidacin (INN) is an experimental antibiotic that acts as a topoisomerase type II inhibitor. It is being studied for the treatment of uncomplicated urinary tract infection (acute cystitis) and infection with Neisseria gonorrhoeae (gonorrhea), including multidrug resistant strains.
|
Antifolates (inhibit bacterial purine metabolism, thereby inhibiting DNA and RNA synthesis) |
|
||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Quinolones (inhibit bacterial topoisomerase and/or DNA gyrase, thereby inhibiting DNA replication) |
|
||||||||||||||||
|
Anaerobic DNA inhibitors |
|
||||||||||||||||
| RNA synthesis |
|
||||||||||||||||
| |||||||||||||||||